Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1615-1618

  Chen, Tseng Shing ^a   Chang, Full Young ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Aspirin; Duodenal ulcer; Helicobacter pylori; Nonsteroidal anti inflammatory drug; Psychophysical stress

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CARBON 13; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; UREA; UREASE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOLISM; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DUODENOSCOPY; DUODENUM BIOPSY; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATIENT REFERRAL; PRIORITY JOURNAL; STRUCTURED INTERVIEW; UREA BREATH TEST;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUODENAL ULCER; ETHANOL; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 57049087543     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335:1233-1235.
2. Marshall BJ, Goodwin CS, Warren JR, et al: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2:1437-1442.
3. Marshall BJ, McGechie DB, Rogers PA, et al: Pyloric campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142:439-444.
4. Borody TJ, George LL, Brandl S, Andrews P, Ostapowicz N, Hyland L, et al: Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991; 86:1154-1157.
5. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JBD: Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999; 94:1834-1840.
6. Laine L, Hopkins RJ, Girardi LS: Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93:1409-1415.
7. Nensey YW, Schubert TT, Bologna SD, Ma CK: Helicobacter pylori-negative duodenal ulcer. Am J Med 1991; 91:15-18.
8. Gisbert JP, Blanco M, Mateos JM, et al: H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci 1999; 44:2295-2302.
9. McColl KEL, El-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, El-Omar E, et al: A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993; 34:762-768.
10. Di Battista R, Bierti L, Benassi R, et al: Prevalence and risk factors in Helicobacter pylori peptic ulcer in an area of northern Italy. Gastroenterology 1997; 112:A102.
11. Kurata JH, Abbey DE: The effect of chronic aspirin use on duodenal and gastric ulcer hospitalization. J Clin Gastroenterol 1990; 12:260-266.
12. Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, and Dodge WE: The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Aliment Pharmacol Ther 2006; 23:1489-1498.
13. Lavenstein S, Prantera C, Varvo V, et al: Patterns of biologic and psychologic risk factors in duodenal ulcer patients. J Clin Gastroenterol 1995; 21:110-117.
14. Bresnick WH, Rask-Madsen C, Hogan DL, Koss MA, Isenberg JI: The effect of acute emotional stress on gastric acid secretion in normal subjects and duodenal ulcer patients. J Clin Gastroenterol 1993; 17:117-122.
15. Weiner H, Thaler M, Reiser MF, Mirsky IA: Relation of specific psychological characteristics to rate of gastric secretion (serum pepsinogen). Psychosom Med 1957; 19:1-10.
16. Walker P, Luther J, Samloff IM, Feldman M: Life events, stress and psychosocial factors in men with peptic ulcer disease: II. Relationships with serum pepsinogen concentrations and behavioral risk factors. Gastroenterology 1988; 94:323-330.
17. Peters MN, Richardson CT: Stressful life events, acid hypersecretion, and ulcer disease. Gastroenterology 1983; 84:114-119.
18. Miwa H, Matsushima H, Terai T, Tanaka H, Kawabe M, Namihisa A, et al: Relapsed duodenal ulcer after cure of Helicobacter pylori infection. J Gastroenterol 1998; 33:556-561.
19. Bresnick WH, Rask-Madsen C, Hogan DL, Koss MA, Isenberg JI: The effect of acute emotional stress on gastric acid secretion in normal subjects and duodenal ulcer patients. J Clin Gastroenterol 1993; 17:117-122.
20. Endo K, Leung FW: Effect of smoking and nicotine on the gastric mucosa: A review of clinical and experimental evidence. Gastroenterology 1994; 107:864-878.
21. Armstrong D, Arnold R, Classen M, et al: RUDER-A prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. Dig Dis Sci 1994; 39:1425-1433.
22. Markiewicz K, Cholewa M, Lukin M: Gastric basal secretion during exercise and restitution in patients with chronic duodenal ulcer. Acta Hepato-Gastroenterol 1979; 26:160-165.
23. Oektedalen O, Guldvog I, Opstad PK, et al: The effect of physical stress on gastric secretion and pancreatic polypeptide levels in man. Scand J Gastroenterol 1984; 19:770-778.
24. Harris AW, Gummett PA, Phull PS, Jacyna MR, Misiewicz JJ, Baron JH: Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output. Aliment Pharmacol Ther 1997; 11(2):331-334.
25. Kurata JH, Nogawa AN: Meta-analysis of risk factors for peptic Ulcer: Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24:2-17.
26. Kikendall JW, Evaul J, Johnson LF: Effect of cigarette smoking on gastrointestinal physiology and non-neoplastic disgestive disease. J Clin Gastroenterol 1984; 6:65-79.
27. Korman MG, Hansky J, Eaves ER, et al: Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 1983; 85:871-874.
28. Eastwood GL: Is smoking still important in the pathogenesis of peptic ulcer disease? J Clin Gastroenterol 1997; 25(Suppl 1):S1-S7.
29. Chen TS, Lee YC, Li FY, Chang FY: Smoking and hyperpepsinogenemia are associated with increased risk for duodenal ulcer in Helicobacter pylori-infected patients. J Clin Gastroenterol 2005; 39:699-703.
30. Borody TJ, George LL, Brandl S, et al: Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. Am J Gastroenterol 1992; 87:1390-1393.
31. Tsai CJ, Lin CY: Seasonal changes in symptomatic duodenal ulcer activity in Taiwan: a comparison between subjects with and without haemorrhage. J Intern Med 1998:244:405-410.
32. Piper DW, Nasiry R, McIntosh J, et al: Smoking, alcohol, analgesics and chronic duodenal ulcer. Scand J Gastroenterol 1984; 19:1015-1021.
33. Jain A, Buddhiraja S, Khurana B, et al: Risk factors for duodenal ulcer in north India. Tropical Gastroenterology 1999; 20:36-39.
34. Willett WC: A prospective study of alcohol, smoking, caffeine, and the risk of duodenal ulcer in men. Epidemiology 1997; 8:420-424.
35. Corrao G, Bagnardi V, Zambon A, Arico S: Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addition 1999; 94:1551-1573.
36. Xia HH-X, Wong BCY, Wong KW, Wong SY, Wong WM, Lai KC, Hu WHC, Chan CK, Lam SK: Clinical and endoscopic characteristics of non- Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001; 15:1875-1882.
37. Chu KM, Kwok KF, Law S, Wong KH: Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics. World J Gastroenterol 2005; 11:3518-3522.
38. Kirk AP, Dooley JS, Hunt RH: Peptic ulceration in patients with chronic liver disease. Dig Dis Sci 1980; 25:756-760.
39. Wu CS, Lin CY, Liaw YF: Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995; 42:424-427.